Amylyx Pharmaceuticals Inc [NASDAQ: AMLX] slipped around -0.16 points on Thursday, while shares priced at $3.92 at the close of the session, down -3.92%.
Compared to the average trading volume of 1.11M shares, AMLX reached a trading volume of 3312601 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about Amylyx Pharmaceuticals Inc [AMLX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AMLX shares is $4.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMLX stock is a recommendation set at 2.71. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Mizuho have made an estimate for Amylyx Pharmaceuticals Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on March 18, 2024. While these analysts kept the previous recommendation, Robert W. Baird raised their target price from $37 to $4. The new note on the price target was released on March 11, 2024, representing the official price target for Amylyx Pharmaceuticals Inc stock. Previously, the target price had yet another drop from $27 to $4, while Leerink Partners kept a Market Perform rating on AMLX stock.
The Average True Range (ATR) for Amylyx Pharmaceuticals Inc is set at 0.28, with the Price to Sales ratio for AMLX stock in the period of the last 12 months amounting to 0.89. The Price to Book ratio for the last quarter was 1.02, with the Price to Cash per share for the same quarter was set at 4.55.
How has AMLX stock performed recently?
Amylyx Pharmaceuticals Inc [AMLX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 13.29. With this latest performance, AMLX shares gained by 36.11% in over the last four-week period, additionally plugging by 97.98% over the last 6 months – not to mention a drop of -78.09% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMLX stock in for the last two-week period is set at 72.38, with the RSI for the last a single of trading hit 73.52, and the three-weeks RSI is set at 70.83 for Amylyx Pharmaceuticals Inc [AMLX]. The present Moving Average for the last 50 days of trading for this stock 2.70, while it was recorded at 3.81 for the last single week of trading, and 5.47 for the last 200 days.
Amylyx Pharmaceuticals Inc [AMLX]: Deeper insight into the fundamentals
Amylyx Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.66 and a Current Ratio set at 4.66.
Earnings analysis for Amylyx Pharmaceuticals Inc [AMLX]
With the latest financial reports released by the company, Amylyx Pharmaceuticals Inc posted 0.3/share EPS, while the average EPS was predicted by analysts to be reported at 0.43/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.13. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMLX.
Insider trade positions for Amylyx Pharmaceuticals Inc [AMLX]
There are presently around $86.51%, or 101.01%% of AMLX stock, in the hands of institutional investors. The top three institutional holders of AMLX stocks are: VANGUARD GROUP INC with ownership of 4.22 million shares, which is approximately 6.2251%. AQR CAPITAL MANAGEMENT LLC, holding 3.34 million shares of the stock with an approximate value of $$6.35 million in AMLX stocks shares; and AQR CAPITAL MANAGEMENT LLC, currently with $$5.07 million in AMLX stock with ownership which is approximately 3.9345%.
